Tharimmune News

Tharimmune Abandons Acquisition of Intract Pharma

WSJNov 22 07:08

Express News | Tharimmune Inc - Increases Board Size to Six

BreakingsNov 22 05:55

What's Going On With Tharimmune Shares Monday?

BenzingaNov 19 00:47

Tharimmune Announces Presentation At AASLD The Liver Meeting

BenzingaNov 18 21:08

Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease

AccesswireNov 18 21:00

Tharimmune Granted European Patent Covering Biodegradable Polymeric Nanoparticles Created For Carrying Therapeutic And Targeting Agents

BenzingaNov 13 21:06

Tharimmune | 10-Q: Q3 2024 Earnings Report

SECNov 8 06:29 · Announcements

10 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaNov 4 20:29

Tharimmune THAR EMA Feedback; Xilio XLO Phase 1C Data

BioPharmCatalystOct 31 04:01

Sector Update: Health Care Stocks Softer Late Afternoon

MT NewswiresOct 31 03:55

Sector Update: Health Care

MT NewswiresOct 31 03:29

Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast

BenzingaOct 31 03:00

Top Midday Gainers

MT NewswiresOct 31 01:45

What's Going On With Tharimmune Shares Wednesday?

BenzingaOct 31 00:31

Trending Stocks Today | Tharimmune Surges 110.83%

October 30th - US stocks trending in regular trading hours.Gainers: $Tharimmune(THAR.US)$ shoots up 110.83% to $4.28 with a turnover of $281.53 million. $Vast Renewables(VSTE.US)$ soars 95.04% to $1.9

Futu NewsOct 31 00:15

Tharimmune Shares Climb on Positive Feedback From EMA on Potential Pruritus Therapy

MT NewswiresOct 30 23:06

Dow Surges Over 150 Points; Alphabet Posts Upbeat Results

BenzingaOct 30 23:04

Tharimmune Receives EMA Feedback On TH104 Clinical Program, Including Guidance On Planned Phase 2 Trial; The Agency Found The Design And Main Features Of The Proposed Phase 2 Study Overall Acceptable With Some Comments, Also Provided General Guidance...

BenzingaOct 30 20:23

Express News | Tharimmune Inc - Expects Topline Data in 2025

BreakingsOct 30 20:17

Express News | Tharimmune - Plans to Initiate Phase 2 Multiple-Ascending Dose Trial in Coming Months to Assess Safety and Tolerability of TH104

BreakingsOct 30 20:17